SNDX
Syndax Pharmaceuticals Inc
17.60$
-3.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7,714.4% | – | -2,047.0% | -498.6% | -747.2% | -474.8% | -231.3% | -153.8% | -101.5% | -77.6% | -41.6% | -87.6% | |
| – | 0.6% | – | 0.1% | 0.0% | 0.0% | 0.6% | 0.1% | -0.4% | 0.0% | 0.0% | 0.0% | -0.1% | |
| – | 1,553.5% | – | 282.7% | 95.5% | 160.1% | 51.8% | 36.3% | 26.3% | 16.4% | 18.6% | 19.3% | 19.6% | |
| – | 4,852.6% | – | -287.8% | 101.0% | 354.0% | -87.0% | -70.5% | -51.0% | -17.2% | -29.4% | 32.7% | -12.1% | |
| – | 0.0% | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.3% | 0.1% | 0.0% | 0.1% | 0.1% | |
| – | -3,039.2% | – | 1,764.3% | 694.8% | -3,502.3% | 469.7% | 110.4% | 157.9% | 119.1% | 59.2% | -23.2% | 69.6% | |
| – | 48,224.4% | – | 19.3% | 24.8% | 4,523.8% | 4.6% | 1.5% | 13.7% | 8.6% | 12.2% | 347.3% | 108.3% | |
| – | 37,470.9% | – | -263.4% | 221.0% | 274.3% | -0.4% | -119.5% | 17.8% | 26.3% | -6.2% | 282.4% | 90.4% | |
| – | -7,714.4% | – | -2,047.0% | -498.6% | -747.2% | -474.8% | -231.3% | -154.1% | -101.6% | -77.6% | -41.6% | -87.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.